Literature DB >> 20096161

The enigmatic autoimmune response in endemic pemphigus foliaceus.

G Flores1, Y Qian, L A Díaz.   

Abstract

Endemic pemphigus foliaceus, known as Fogo Selvagem (FS) in Brazil, is a disease characterized by subcorneal blisters and IgG4 anti-dermoglein 1 (Dsg1) autoantibodies. Epidemiological studies of FS strongly an environmental etiology. A 15-year surveillance of the Limao Verde Amerindian reservation in Brazil has uncovered information on the transition of the autoimmune response from the pre-clinical stage to disease state. This incubation time may evolve over several years. The serological markers of the pre-clinical state of FS are IgM anti-Dsg1, IgE and non-IgG4 autoantibodies against Dsg1. The disease stage of FS is characterized by the rise of pathogenic IgG4 anti-Dsg1 autoantibodies. In this review, the authors reviewed the literature on the relevance of the humoral autoimmune response of FS as well as the possible environmental triggers of anti-Dsg1 autoantibody formation. Based on epidemiological observations, the authors hypothesize that the pathogenic IgG4 response in FS may be triggered by hematophagous insect bites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20096161     DOI: 10.1016/s0001-7310(09)73377-0

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  3 in total

1.  IgG autoantibody response against keratinocyte cadherins in endemic pemphigus foliaceus (fogo selvagem).

Authors:  Gustavo Flores; Donna A Culton; Phillip Prisayanh; Bahjat F Qaqish; Kirk James; Mike Maldonado; Valeria Aoki; Gunter Hans-Filho; Evandro A Rivitti; Luis A Diaz
Journal:  J Invest Dermatol       Date:  2012-07-19       Impact factor: 8.551

2.  Prevalence of Metabolic Syndrome and its components in a Brazilian sample of pemphigus patients.

Authors:  Marcela Vendruscolo Ambiel; Ana Maria Roselino
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

3.  Severe visceral leishmaniasis and COVID-19 coinfection in an immunosuppressed patient.

Authors:  Luciamáre Perinetti Alves Martins; Josianne Thomazini Fukasawa; Mirella Beni Balbino Ferreira Messias; Roberto Esteves Pires Castanho; Leticia Abrantes Andrade; Márcia Aparecida Sperança; Rodrigo Buzinaro Suzuki
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-03-11       Impact factor: 1.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.